...
首页> 外文期刊>Organometallics >Aryl-oxazoline chelates of first-row transition metals: Structures of {Κ-C,N-(o-C_6H_4)CMe_2(COCH _2CMe_2N)}FeCl(py) and [(Κ-C,N-(o-C_6H _4)CMe_2(COCH_2CMe_2N)}Cr(μ-Cl)] _2
【24h】

Aryl-oxazoline chelates of first-row transition metals: Structures of {Κ-C,N-(o-C_6H_4)CMe_2(COCH _2CMe_2N)}FeCl(py) and [(Κ-C,N-(o-C_6H _4)CMe_2(COCH_2CMe_2N)}Cr(μ-Cl)] _2

机译:第一行过渡金属的芳基-恶唑啉螯合物:{Κ-C,N-(o-C_6H_4)CMe_2(COCH _2CMe_2N)} FeCl(py)和[(Κ-C,N-(o-C_6H _4) CMe_2(COCH_2CMe_2N)} Cr(μ-Cl)] _2

获取原文
获取原文并翻译 | 示例
           

摘要

Aryl-oxazoline synthons have been explored for the preparation of strong-field first-row transition metal chelate species. With 4,4-dimethyl-2-phenyloxazoline (HPhOx), no CH bond activations afforded complexation, and aside from Zn(Κ-C,N-4,4-Me_2-2-(o-C _6H_4)oxazoline)2 (Zn(PhOx)_2), aryl-coupling reactions were noted with 4,4-dimethyl-2-(2-lithiophenyl)oxazoline (LiPhOx) and MX_2; [Κ-N,N-{4,4-Me_2-(2-o-C _6H_4)-2-oxazoline}_2]CoCl_2 (1-Co) was structurally characterized. Metalations with 4,4-dimethyl-2-benzyloxazoline (PhCH_2Ox) were prone to deprotonation, as exemplified by (Me _2N)_3Ti(η-N-(4,4-dimethyl-(2-CHPh)oxazoline)) (2) and bis-N,N′-(4,4-dimethyl-(2-pyridylmethylyl)oxazoline)Fe (3). Oxidative addition of 4,4-dimethyl-2-(2-bromophenylpropan-2-yl)oxazoline (BrPhCMe _2Ox) to Ni(COD)_2 provided [{Κ-C,N-(o-C _6H_4)CMe_2(COCH_2CMe _2N)}Ni]_2(μ-Br)_2 (4_2). With 4,4-dimethyl-2-(2-lithiophenylpropan-2-yl)oxazoline (LiPhCMe_2Ox), salt (FeBr_2) metathesis proved uncompetitive with oxazoline ring-opening, as exhibited by [{Κ-N,O-C_6H_4CMe _2C=NCMe_2CH_2(μ-O)-}BrFe{Κ-N,O-C _6H_4CMe_2C=NCMe_2CH_2(μ-O) -}FeBr]Li {Κ-N,O-C_6H_4CMe_2-C=NCMe _2CH_2(μ-O)-}(DME) (5-Fe_2Li). Metatheses utilizing (PhCMe_2Ox)_2Zn, prepared from LiPhCMe _2Ox and ZnCl_2, gave structurally characterized dichromium, i.e., [{Κ-C,N-(o-C_6H_4)CMe_2 (COCH _2CMe_2N)}Cr]_2(μ-Cl)_2 (6 _2), and iron, i.e., {Κ-C,N-{(o-C_6H _4)CMe_2(COCH_2CMe_2N)}Fe(py)Cl (7) products. Bis-aryloxazoline metal complexes proved difficult to prepare, with {Κ-C,N-(o-C_6H_4)CMe_2(COCH _2CMe_2N)}_2M (M = Ni, 9) the only clear example, although NMR evidence exists for M = Fe (8).
机译:已经研究了芳基-恶唑啉合成子以制备强场第一行过渡金属螯合物。使用4,4-二甲基-2-苯基恶唑啉(HPhOx)时,除Zn(Κ-C,N-4,4-Me_2-2-(oC _6H_4)恶唑啉)2(Zn( PhOx)_2),芳基偶联反应与4,4-二甲基-2-(2-lithiophenyl)恶唑啉(LiPhOx)和MX_2; [K-N,N- {4,4-Me_2-(2-o-C _6H_4)-2-恶唑啉} _2] CoCl_2(1-Co)的结构表征。如(Me _2N)_3Ti(η-N-(4,4-二甲基-(2-CHPh)恶唑啉))所示,用4,4-二甲基-2-苄基恶唑啉(PhCH_2Ox)的金属易于去质子化(2)和双-N,N′-(4,4-二甲基-(2-吡啶基甲基甲酰基)恶唑啉)Fe(3)。将氧化的4,4-二甲基-2-(2-溴苯基丙烷-2-基)恶唑啉(BrPhCMe _2Ox)加到Ni(COD)_2中[[Κ-C,N-(oC _6H_4)CMe_2(COCH_2CMe _2N)} Ni] _2(μ-Br)_2(4_2)。用[{Κ-N,O-C_6H_4CMe _2C = NCMe_2CH_2(μ-O)-} BrFe {Κ-N,OC _6H_4CMe_2C = NCMe_2CH_2(μ-O)-} FeBr] Li {Κ-N,O-C_6H_4CMe_2-C = NCMe _2CH_2(μ-O)-}(DME )(5-Fe_2Li)。利用由LiPhCMe _2Ox和ZnCl_2制备的(PhCMe_2Ox)_2Zn进行复分解,得到结构特征重铬,即[{Κ-C,N-(o-C_6H_4)CMe_2(COCH _2CMe_2N)} Cr] _2(μ-Cl)_2( 6 _2)和铁,即{Κ-C,N-{(o-C_6H _4)CMe_2(COCH_2CMe_2N)} Fe(py)Cl(7)产物。事实证明很难制备双芳基恶唑啉金属配合物,尽管有NMR证据表明M = Fe,{K-C,N-(o-C_6H_4)CMe_2(COCH _2CMe_2N)} _ 2M(M = Ni,9)是唯一清楚的例子。 (8)。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号